Executives from Definium Therapeutics (NASDAQ:DFTX) outlined clinical, regulatory, and commercial priorities for its lead ...
VNS Health And Vitalic Release Early Findings From a Telehealth-Based Behavioral Health Program Targeting High-Risk ...
MyNewsLA.com on MSN
Sentencing vacated for ex-therapist in child pornography case
A sentencing hearing was taken off the court’s calendar Monday for a formerly licensed Beverly Hills-based marriage and family therapist who admitted distributing child sexual abuse material. When he ...
Definium Therapeutics (NASDAQ:DFTX) outlined its clinical pipeline and upcoming data catalysts at the Leerink Partners Global ...
A web-based tool that incorporates patient preference in antidepressant selection was associated with a significant decrease ...
Market News Updates News Commentary - Treatments for Generalized Anxiety Disorder (GAD) are getting better and more accessible, which is good news for millions of people dealing with constant worry ...
Detailed price information for Definium Therapeutics Inc (DFTX-Q) from The Globe and Mail including charting and trades.
Over 40 million American adults – approximately 19% – live with an anxiety disorder, according to the National Institutes of Health. Studies show this anxiety is most prevalent in young people. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results